- Home
- NXTC vs BRN Comparison
NXTC vs BRN Comparison
Compare NXTC & BRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXTC
- BRN
- Stock Information
- Founded
- NXTC 2015
- BRN 1956
- Country
- NXTC United States
- BRN United States
- Employees
- NXTC N/A
- BRN N/A
- Industry
- NXTC Biotechnology: Pharmaceutical Preparations
- BRN Oil & Gas Production
- Sector
- NXTC Health Care
- BRN Energy
- Exchange
- NXTC Nasdaq
- BRN Nasdaq
- Market Cap
- NXTC 20.6M
- BRN 17.6M
- IPO Year
- NXTC 2019
- BRN N/A
- Fundamental
- Price
- NXTC $0.40
- BRN $1.62
- Analyst Decision
- NXTC Strong Buy
- BRN
- Analyst Count
- NXTC 2
- BRN 0
- Target Price
- NXTC $3.50
- BRN N/A
- AVG Volume (30 Days)
- NXTC 99.1K
- BRN 20.4K
- Earning Date
- NXTC 03-06-2025
- BRN 05-13-2025
- Dividend Yield
- NXTC N/A
- BRN N/A
- EPS Growth
- NXTC N/A
- BRN N/A
- EPS
- NXTC N/A
- BRN N/A
- Revenue
- NXTC N/A
- BRN $20,046,000.00
- Revenue This Year
- NXTC N/A
- BRN N/A
- Revenue Next Year
- NXTC N/A
- BRN N/A
- P/E Ratio
- NXTC N/A
- BRN N/A
- Revenue Growth
- NXTC N/A
- BRN N/A
- 52 Week Low
- NXTC $0.35
- BRN $1.26
- 52 Week High
- NXTC $2.49
- BRN $3.20
- Technical
- Relative Strength Index (RSI)
- NXTC 22.20
- BRN 48.22
- Support Level
- NXTC $0.49
- BRN $1.26
- Resistance Level
- NXTC $0.67
- BRN $1.79
- Average True Range (ATR)
- NXTC 0.09
- BRN 0.08
- MACD
- NXTC -0.02
- BRN -0.00
- Stochastic Oscillator
- NXTC 12.74
- BRN 33.33
About NXTC NextCure Inc.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases, and NC181, for Alzheimer's disease.
About BRN Barnwell Industries Inc.
Barnwell Industries Inc is an oil and gas firm. Its areas of operations include acquiring, developing, producing, and selling oil and natural gas. The company acquires and develops crude oil and natural gas assets. The company's operating segment includes Oil and natural gas, Contract drilling, Land investment, and Others. It generates maximum revenue from the Oil and natural gas segment. It operates in two geographical segments the United States, which generates a majority of revenue, and Canada.